The instant invention provides methods for treating a solid tumor in a subject comprising modulating nitric oxide production in the tumor to normalize tumor vasculature and administering an anti-tumor therapy to the subject. The invention further provides methods of treating a solid tumor in a subject comprising selectively increasing cyclic guanosine monophosphate (cGMP) or cGMP dependent protein kinase G production in the tumor vasculature to an amount effective to normalize tumor vasculature and administering an anti-tumor therapy to the subject.
Modulation Of Nitric Oxide Signaling To Normalize Tumor Vasculature
Rakesh K. Jain - Wellesley MA, US Dai Fukumura - Newton MA, US Satoshi Kashiwagi - Boston MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 38/18 A61K 31/7088 A61P 35/00
US Classification:
514 12, 514 44 R
Abstract:
The instant invention provides methods for treating a solid tumor in a subject comprising modulating nitric oxide production in the tumor to normalize tumor vasculature and administering an anti-tumor therapy to the subject. The invention further provides methods of treating a solid tumor in a subject comprising selectively increasing cyclic guanosine monophosphate (cGMP) or cGMP dependent protein kinase G production in the tumor vasculature to an amount effective to normalize tumor vasculature and administering an anti-tumor therapy to the subject.